Global Cardiovascular Drug-Eluting Stents(DES) Market Growth 2025-2031

The global Cardiovascular Drug-Eluting Stents(DES) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Cardiovascular Drug-Eluting Stents(DES) Industry Forecast” looks at past sales and reviews total world Cardiovascular Drug-Eluting Stents(DES) sales in 2024, providing a comprehensive analysis by region and market sector of projected Cardiovascular Drug-Eluting Stents(DES) sales for 2025 through 2031. With Cardiovascular Drug-Eluting Stents(DES) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Drug-Eluting Stents(DES) industry.

This Insight Report provides a comprehensive analysis of the global Cardiovascular Drug-Eluting Stents(DES) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Drug-Eluting Stents(DES) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiovascular Drug-Eluting Stents(DES) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Drug-Eluting Stents(DES) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Drug-Eluting Stents(DES).

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Drug-Eluting Stents(DES) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Passive Coating

Active Coating

Segmentation by Application:

Hospital

Clinic

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

MIV Therapeutics

Orbusneich

Promed Medical

Relisys Medical

Reva Medical

Sahajanand

Sino Medical

Sorin

Terumo Medical

Abbott Vascular

Advantec Vascular

B.Braun Melsengen AG

Biosensors

Boston Scientific

MicroPort Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiovascular Drug-Eluting Stents(DES) market?

What factors are driving Cardiovascular Drug-Eluting Stents(DES) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiovascular Drug-Eluting Stents(DES) market opportunities vary by end market size?

How does Cardiovascular Drug-Eluting Stents(DES) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.